title: Patients' knowledge and perspectives on wet age-related macular degeneration and its treatment.
abstract: CONCLUSIONS
  There have been no studies examining the level of understanding age-related macular degeneration (ARMD) patients have about their disease, or their perceptions about intraocular injections as treatment. In this study, patient knowledge about ARMD risk factors was low but patients appeared more optimistic than fearful when confronted with intraocular antivascular endothelial growth factor (anti-VEGF) injections as treatment.
  
  
  OBJECTIVE
  In recent years there has been an increase in our understanding of wet ARMD, and a dramatic shift in the treatment paradigm. However, to our knowledge, no studies have examined how much ARMD patients understand their disease, or how they feel about receiving intraocular injections as treatment. The primary objectives of this study are to identify areas in which ARMD patients may be uninformed about their disease, and to recognize specific fears or expectations that patients may have regarding treatment with intraocular anti-VEGF injections.
  
  
  METHODS
  Prospective, survey-based study.
  
  
  METHODS
  This is a prospective survey-based study. An anonymous 32-item questionnaire was compiled and distributed to patients with wet ARMD who underwent at least one intraocular anti-VEGF injection. Eighty-three patients from a retina practice in a suburban setting completed the questionnaire that gauged both their knowledge of ARMD and their perspectives on its treatment. Data was analyzed using chi-square testing.
  
  
  RESULTS
  Seventy-eight percent of patients received most of their knowledge of ARMD from their physician. Eighty-nine percent of patients prefer to receive more information on ARMD, if needed, directly from their physician. Only 21%, 48%, 37%, 48%, and 36%, respectively, correctly identified how diet, special vitamins, high blood pressure, family history, and smoking can affect ARMD. Sixty percent felt somewhat afraid or very afraid about getting their first intraocular injection but this did not correlate with pain or discomfort during treatment (P = 0.075, P = 0.117). Eighty-nine percent were very satisfied and 11% were somewhat satisfied with the explanation their physician gave them about the injections. Eighty percent reported feeling hopeful (significantly more than any other emotion) when they were first told they needed an intraocular injection for treatment of their disease.
  
  
  CONCLUSIONS
  Knowledge of risk factors and risk factor modification among patients with ARMD is low. Since the vast majority of ARMD patients prefer to receive information directly from their physician, patient education is crucial in improving risk factor modification and alleviating fears of treatment. With the advent of anti-VEGF agents, patients appear more hopeful of regaining vision than they are fearful of treatment with intraocular injections.
authors.affiliation: Department of Ophthalmology, Akron OH, USA. kandula7@yahoo.com
authors.forename: Sushma
authors.initials: S
authors.lastname: Kandula
authors.forename: Jeffrey C
authors.initials: JC
authors.lastname: Lamkin
authors.forename: Teresa
authors.initials: T
authors.lastname: Albanese
authors.forename: Deepak P
authors.initials: DP
authors.lastname: Edward
references.citation: N Engl J Med. 2006 Oct 5;355(14):1419-31
references.pmid: 17021318
references.citation: Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3771-7
references.pmid: 12939290
references.citation: Arch Ophthalmol. 2001 Jul;119(7):1050-8
references.pmid: 11448327
references.citation: Arch Ophthalmol. 2004 Apr;122(4):564-72
references.pmid: 15078675
references.citation: Am J Epidemiol. 2001 Aug 1;154(3):207-11
references.pmid: 11479184
references.citation: Arch Ophthalmol. 2007 May;125(5):671-9
references.pmid: 17502507
references.citation: Arch Ophthalmol. 2003 Feb;121(2):211-7
references.pmid: 12583787
references.citation: Ophthalmology. 1992 Jun;99(6):933-43
references.pmid: 1630784
references.citation: Can J Ophthalmol. 2003 Feb;38(1):27-32
references.pmid: 12608514
references.citation: Am J Ophthalmol. 2006 Jul;142(1):1-9
references.pmid: 16815245
references.citation: Arch Ophthalmol. 2006 Jul;124(7):995-1001
references.pmid: 16832023
references.citation: Patient Educ Couns. 1998 May;34(1):63-73
references.pmid: 9697558
references.citation: Arch Ophthalmol. 1998 Dec;116(12):1646-51
references.pmid: 9869796
references.citation: Am J Ophthalmol. 1997 Feb;123(2):199-206
references.pmid: 9186125
references.citation: Ophthalmology. 2002 Jun;109(6):1092-7
references.pmid: 12045049
references.citation: Ophthalmology. 2003 Jun;110(6):1273-80
references.pmid: 12799274
references.citation: Ophthalmology. 2006 Mar;113(3):363-372.e5
references.pmid: 16458968
references.citation: Br J Ophthalmol. 2010 Jan;94(1):2-13
references.pmid: 19443462
references.citation: Arch Ophthalmol. 2007 Jan;125(1):55-62
references.pmid: 17210852
references.citation: Arch Ophthalmol. 2007 Aug;125(8):1089-95
references.pmid: 17698756
references.citation: Klin Monbl Augenheilkd. 2005 Jun;222(6):480-4
references.pmid: 15973626
references.citation: Arch Ophthalmol. 2007 Sep;125(9):1225-32
references.pmid: 17846363
references.citation: Ophthalmology. 2005 Apr;112(4):533-9
references.pmid: 15808240
references.citation: Arch Ophthalmol. 2001 Oct;119(10):1417-36
references.pmid: 11594942
references.citation: Clin Exp Ophthalmol. 2006 Jan-Feb;34(1):9-14
references.pmid: 16451252
references.citation: Ophthalmology. 2008 Jun;115(6):1032-1038.e4
references.pmid: 18096234
references.citation: Aust Fam Physician. 2009 Mar;38(3):172-6
references.pmid: 19283260
references.citation: N Engl J Med. 2006 Oct 5;355(14):1432-44
references.pmid: 17021319
references.citation: Curr Med Res Opin. 2009 Jun;25(6):1413-20
references.pmid: 19422281
references.citation: Am J Ophthalmol. 2004 Apr;137(4):750-2
references.pmid: 15059717
references.citation: J Travel Med. 2005 Apr;12 Suppl 1:S41-6
references.pmid: 16225805
references.citation: Ophthalmology. 2008 Jul;115(7):1203-8
references.pmid: 17997484
references.citation: Ophthalmology. 2004 Jul;111(7):1280-7
references.pmid: 15234127
references.citation: Arch Ophthalmol. 2009 Apr;127(4):533-40
references.pmid: 19365036
references.citation: Arch Ophthalmol. 1992 Dec;110(12):1701-8
references.pmid: 1281403
references.citation: Arch Ophthalmol. 2000 Mar;118(3):351-8
references.pmid: 10721957
references.citation: Eye (Lond). 2005 Sep;19(9):935-44
references.pmid: 16151432
references.citation: Retina. 2006 Apr;26(4):383-90
references.pmid: 16603955
references.citation: Arch Ophthalmol. 2007 Jan;125(1):49-54
references.pmid: 17210851